The Top 5 Vaccine Companies by Revenue in 2012

In Featured on App by tim peplowLeave a Comment

top 5 vaccine companies revenue (racing five)

The top 5 vaccine companies captured more than 90% of vaccine sales in 2012, report FierceVaccines. Using figures from EvaluatePharma, these are the Top 5 vaccine companies by revenue in 2012:

1. Sanofi

Manufacturers of the PENT Act-HIB (DTPw, Hib & polio) vaccine – one of the top-selling vaccines that generated $1.5b in 2012.

2. Merck

Manufacturers of big-seller Gardasil, the vaccine against human papillomavirus.

3. GlaxoSmithKline

GSK recently announced a joint venture with Indian vaccine company Biological E to develop a 6-in-1 vaccine against polio, diphtheria, tetanus, whooping cough, hepatitis B and haemophilus influezae b.

4. Pfizer

Of course, Pfizer is responsible for Prevnar 13 – the pneumococcal conjugate vaccine that generated over $3.7bn in 2012, making it the best-selling vaccine in the world.

5. Novartis

Manufacturers of Bexsero – the meningococcal group B vaccine that was approved by the European Commission in January 2013.

What do you think about the list? Are there any surprises? Do you expect there to be any changes to the order in the coming years?

You can join our discussion on LinkedIn or leave a comment below, I'd love to hear what you think.

If you'd like to know more about strategy and innovation in vaccines, you might like to consider attending the World Vaccine Congress and Expo 2013 on the 16-18 April 2013, Gaylord National Hotel and Convention Center, Washington DC. You can download the brochure here.

Leave a Comment

Current ye@r *